[Federal Register Volume 64, Number 108 (Monday, June 7, 1999)]
[Notices]
[Pages 30359-30360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-14236]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 23, 1999, Radian
International LLC, 14050 Summit Drive, Suite 121, P.O. Box 201088,
Austin, Texas 78720-1088, made application by renewal to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
N-Ethylamphetamine (1475).................. I
N,N-Dimethylamphetamine (1480)............. I
Aminorex (1585)............................ I
4-Methylaminorex (cis isomer) (1590)....... I
Methaqualone (2565)........................ I
Alpha-Ethyltryptamine (7249)............... I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Mescaline (7381)........................... I
3,4,5-Trimethoxyamphetamine (7390)......... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
4-Methyl-2,5-dimethoxyamphetamine (7395)... I
2,5-Dimethoxyamphetamine (7396)............ I
2,5-Dimethoxy-4-ethylamphetamine (7399).... I
3,4-Methylenedioxyamphetamine (7400)....... I
5-Methoxy-3,4-methylenedioxyamphetamine I
(7401).
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylene-............................. I
dioxy-meth-amphetamine.....................
(7405).....................................
4-Methoxyamphetamine (7411)................ I
Bufotenine (7433).......................... I
Diethyltryptamine (7434)................... I
Dimethyltryptamine (7435).................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
Codeine-N-oxide (9053)..................... I
Dihydromorphine (9145)..................... I
Heroin (9200).............................. I
Morphine-N-oxide (9307).................... I
Normorphine (9313)......................... I
Pholcodine (9314).......................... I
Acetylmethadol (9601)...................... I
Allyprodine (9602)......................... I
Alphacetylmethadol except Levo- I
Alphacetylmethadol (9603).
Alphameprodine (9604)...................... I
Alphamethadol (9605)....................... I
Betacetylmethadol (9607)................... I
Betameprodine (9608)....................... I
Betamethadol (9609)........................ I
Betaprodine (9611)......................... I
Hydromorphinol (9627)...................... I
Noracymethadol (9633)...................... I
Norlevorphanol (9634)...................... I
Normethadone (9635)........................ I
Trimeperidine (9646)....................... I
Para-Fluorofentanyl (9812)................. I
3-Methylfentanyl (9813).................... I
Alpha-methylfentanyl (9814)................ I
Acetyl-alpha-methylfentanyl (9815)......... I
Beta-hydroxyfentanyl (9830)................ I
Beta-hydroxy-3-methylfentanyl (9831)....... I
Alpha-Methylthiofentanyl (9832)............ I
3-Methylthiofentanyl (9833)................ I
Thiofentanyl (9835)........................ I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Phenmetrazine (1631)....................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Nabilone (7379)............................ II
1-Phenylcyclohexylamine (7460)............. II
Phencyclidine (7471)....................... II
1-Piperidino-.............................. II
cyclohexane-...............................
carbonitrile (8603)........................
Alphaprodine (9010)........................ II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hyromorphone (9150)........................ II
Diphenoxylate (9170)....................... II
Benzoylecgonine (9180)..................... II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone-intermediate (9254).............. II
Morphine (9300)............................ II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Alfentanile (9737)......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The firm plans to manufacture small quantities of the listed
controlled substances to make deuterated and non-deuterated drug
reference standards which will be distributed to analytical and
forensic laboratories for drug testing programs.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, DC 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than August 6, 1999.
[[Page 30360]]
Dated: May 26, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 99-14236 Filed 6-4-99; 8:45 am]
BILLING CODE 4410-09-M
